Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024
Compare Balance Sheet Results of Anuh Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.06
39.85
-14.79
-37.11%
Share Warrants & Outstandings
Total Reserve
300.97
40.57
260.40
641.85%
Shareholder's Funds
326.02
80.42
245.60
305.40%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
38.36
-38.36
-100.00%
Secured Loans
0.00
4.63
-4.63
-100.00%
Unsecured Loans
0.00
33.72
-33.72
-100.00%
Deferred Tax Assets / Liabilities
-2.08
2.23
-4.31
-193.27%
Other Long Term Liabilities
0.06
0.00
0.06
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
2.03
0.24
1.79
745.83%
Total Non-Current Liabilities
0.01
40.83
-40.82
-99.98%
Current Liabilities
Trade Payables
156.84
19.64
137.20
698.57%
Other Current Liabilities
11.00
11.78
-0.78
-6.62%
Short Term Borrowings
10.50
19.99
-9.49
-47.47%
Short Term Provisions
0.17
8.64
-8.47
-98.03%
Total Current Liabilities
178.51
60.05
118.46
197.27%
Total Liabilities
504.55
181.30
323.25
178.30%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
111.06
35.68
75.38
211.27%
Less: Accumulated Depreciation
61.36
12.87
48.49
376.77%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
49.70
22.82
26.88
117.79%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.27
0.00
0.27
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
51.95
0.00
51.95
0.00%
Long Term Loans & Advances
2.64
0.00
2.64
0.00%
Other Non Current Assets
15.30
0.00
15.30
0.00%
Total Non-Current Assets
128.38
22.82
105.56
462.58%
Current Assets Loans & Advances
Current Investments
53.86
0.91
52.95
5,818.68%
Inventories
74.48
50.26
24.22
48.19%
Sundry Debtors
215.87
75.00
140.87
187.83%
Cash and Bank
19.74
1.45
18.29
1,261.38%
Other Current Assets
11.48
0.03
11.45
38,166.67%
Short Term Loans and Advances
0.75
30.83
-30.08
-97.57%
Total Current Assets
376.17
158.48
217.69
137.36%
Net Current Assets (Including Current Investments)
197.66
98.43
99.23
100.81%
Total Current Assets Excluding Current Investments
322.31
157.57
164.74
104.55%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
504.55
181.30
323.25
178.30%
Contingent Liabilities
25.26
1.15
24.11
2,096.52%
Total Debt
10.50
58.35
-47.85
-82.01%
Book Value per share (adjusted)
32.53
20.18
12.35
61.20%
Annual - Borrowings
Borrowings 10.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 422.39% vs 0.00% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -84.62% vs -53.57% in Mar 2024
Annual - Fixed Assets
Fixed Assets 49.97 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 23.50% vs -22.19% in Mar 2024
Annual - Investments
Investments 51.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.55% vs 5.12% in Mar 2024
Annual - Current Assets
Current Assets 376.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.12% vs 10.05% in Mar 2024






